Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study

BackgroundIntra-abdominal candidiasis (IAC) is the predominant type of invasive candidiasis with high mortality in critically ill patients. This study aimed to investigate whether the polymerase chain reaction (PCR) assay for detecting Candida DNA in peritoneal fluids (PF) is useful in diagnosing an...

Full description

Bibliographic Details
Main Authors: Min Xie, Jin Shao, Zhe Wan, Ting Yan, Sainan Zhu, Shuangling Li, Jin Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1070688/full
_version_ 1828071072091602944
author Min Xie
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Zhe Wan
Zhe Wan
Zhe Wan
Zhe Wan
Ting Yan
Sainan Zhu
Shuangling Li
Jin Yu
Jin Yu
Jin Yu
Jin Yu
author_facet Min Xie
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Zhe Wan
Zhe Wan
Zhe Wan
Zhe Wan
Ting Yan
Sainan Zhu
Shuangling Li
Jin Yu
Jin Yu
Jin Yu
Jin Yu
author_sort Min Xie
collection DOAJ
description BackgroundIntra-abdominal candidiasis (IAC) is the predominant type of invasive candidiasis with high mortality in critically ill patients. This study aimed to investigate whether the polymerase chain reaction (PCR) assay for detecting Candida DNA in peritoneal fluids (PF) is useful in diagnosing and management of IAC in high-risk patients in intensive care unit (ICU).MethodsA prospective single-center cohort study of surgical patients at high risk for IAC was conducted in the ICU. PF was collected from the abdominal drainage tubes (within 24 h) or by percutaneous puncture. Direct PF smear microscopy, PF culture, blood culture, and serum (1–3)-β-D-glucan were performed in all patients. For Candida PCR assay, the ITS1/ITS4 primers that targeted the ITS1-5.8 s-ITS2 regions were used for PCR, and sequencing analysis was used to identify the pathogen at the species level. IAC was defined according to the 2013 European consensus criteria.ResultsAmong 83 patients at high risk for IAC, the IAC criteria were present in 17 (20.5%). The sensitivity and specificity of the Candida PCR assay were 64.7 and 89.4%, respectively, and the area under the receiver operating characteristic curve was 0.77 (95% CI: 0.63–0.91). In this cohort, the positive predictive value and negative predictive value were 90.8% (95% CI: 80.3–96.2%) and 61.1% (95% CI: 36.1–81.7%), respectively. Diagnostic consistency was moderate (kappa 0.529, p < 0.001) according to the 2013 European consensus criteria.ConclusionDetection of Candida DNA in PF using PCR can be considered an adjunct to existing routine diagnostic tools which may optimize the diagnosis and antifungal treatment of IAC in high-risk patients in the ICU.
first_indexed 2024-04-11T00:47:28Z
format Article
id doaj.art-0888758fc88442b88c1dd72932bc7056
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-11T00:47:28Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-0888758fc88442b88c1dd72932bc70562023-01-05T12:46:25ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-01-011310.3389/fmicb.2022.10706881070688Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort studyMin Xie0Jin Shao1Jin Shao2Jin Shao3Jin Shao4Jin Shao5Zhe Wan6Zhe Wan7Zhe Wan8Zhe Wan9Ting Yan10Sainan Zhu11Shuangling Li12Jin Yu13Jin Yu14Jin Yu15Jin Yu16Department of Critical Care Medicine, Peking University First Hospital, Peking University, Beijing, ChinaDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, ChinaResearch Center for Medical Mycology, Peking University, Beijing, ChinaBeijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, ChinaNational Clinical Research Center for Skin and Immune Diseases, Beijing, ChinaDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, ChinaDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, ChinaResearch Center for Medical Mycology, Peking University, Beijing, ChinaBeijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, ChinaNational Clinical Research Center for Skin and Immune Diseases, Beijing, ChinaDepartment of Critical Care Medicine, Peking University First Hospital, Peking University, Beijing, ChinaDepartment of Biostatistics, Peking University First Hospital, Peking University, Beijing, ChinaDepartment of Critical Care Medicine, Peking University First Hospital, Peking University, Beijing, ChinaDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, ChinaResearch Center for Medical Mycology, Peking University, Beijing, ChinaBeijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, ChinaNational Clinical Research Center for Skin and Immune Diseases, Beijing, ChinaBackgroundIntra-abdominal candidiasis (IAC) is the predominant type of invasive candidiasis with high mortality in critically ill patients. This study aimed to investigate whether the polymerase chain reaction (PCR) assay for detecting Candida DNA in peritoneal fluids (PF) is useful in diagnosing and management of IAC in high-risk patients in intensive care unit (ICU).MethodsA prospective single-center cohort study of surgical patients at high risk for IAC was conducted in the ICU. PF was collected from the abdominal drainage tubes (within 24 h) or by percutaneous puncture. Direct PF smear microscopy, PF culture, blood culture, and serum (1–3)-β-D-glucan were performed in all patients. For Candida PCR assay, the ITS1/ITS4 primers that targeted the ITS1-5.8 s-ITS2 regions were used for PCR, and sequencing analysis was used to identify the pathogen at the species level. IAC was defined according to the 2013 European consensus criteria.ResultsAmong 83 patients at high risk for IAC, the IAC criteria were present in 17 (20.5%). The sensitivity and specificity of the Candida PCR assay were 64.7 and 89.4%, respectively, and the area under the receiver operating characteristic curve was 0.77 (95% CI: 0.63–0.91). In this cohort, the positive predictive value and negative predictive value were 90.8% (95% CI: 80.3–96.2%) and 61.1% (95% CI: 36.1–81.7%), respectively. Diagnostic consistency was moderate (kappa 0.529, p < 0.001) according to the 2013 European consensus criteria.ConclusionDetection of Candida DNA in PF using PCR can be considered an adjunct to existing routine diagnostic tools which may optimize the diagnosis and antifungal treatment of IAC in high-risk patients in the ICU.https://www.frontiersin.org/articles/10.3389/fmicb.2022.1070688/fullintra-abdominal candidiasisPCR assayCandida spp.intensive care unitperitoneal fluid
spellingShingle Min Xie
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Jin Shao
Zhe Wan
Zhe Wan
Zhe Wan
Zhe Wan
Ting Yan
Sainan Zhu
Shuangling Li
Jin Yu
Jin Yu
Jin Yu
Jin Yu
Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
Frontiers in Microbiology
intra-abdominal candidiasis
PCR assay
Candida spp.
intensive care unit
peritoneal fluid
title Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
title_full Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
title_fullStr Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
title_full_unstemmed Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
title_short Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study
title_sort detection of candida dna in peritoneal fluids by pcr assay optimizing the diagnosis and treatment for intra abdominal candidiasis in high risk icu patients a prospective cohort study
topic intra-abdominal candidiasis
PCR assay
Candida spp.
intensive care unit
peritoneal fluid
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.1070688/full
work_keys_str_mv AT minxie detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinshao detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinshao detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinshao detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinshao detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinshao detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT zhewan detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT zhewan detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT zhewan detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT zhewan detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT tingyan detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT sainanzhu detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT shuanglingli detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinyu detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinyu detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinyu detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy
AT jinyu detectionofcandidadnainperitonealfluidsbypcrassayoptimizingthediagnosisandtreatmentforintraabdominalcandidiasisinhighriskicupatientsaprospectivecohortstudy